全球藥物分析測試外包市場

Pharmaceutical Analytical Testing Outsourcing

出版日期: 2024年11月13日 | 出版商:

Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球藥物分析測試外包市場預計將達到163億美元

2023年全球藥物分析測試外包市場估計為103億美元，預計到2030年將達到163億美元，2023年至2030年複合年成長率為6.8%。生物分析測試服務是本報告分析的細分市場之一，預計複合年成長率為 8.0%，到分析期結束時將達到 64 億美元。分析期間分析方法開發和驗證服務業的複合年成長率預計為 6.8%。

美國市場預計28億美元，中國預計複合年成長率6.2%

預計2023年美國藥品分析測試外包市場規模將達28億美元。中國作為世界第二大經濟體，預計2030年市場規模將達25億美元，2023-2030年分析期間複合年成長率為6.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.5% 和 5.2%。在歐洲，德國預計複合年成長率為 5.3%。

全球藥物分析測試外包市場－主要趨勢與促進因素總結

藥品分析測試外包產業如何發展？

過去二十年來，藥物分析測試外包產業經歷了重大發展。主要促進因素是藥物開發、監管監督和成本效率需求日益增加的複雜性。傳統上，製藥公司在內部進行大部分分析測試，並管理藥物開發的所有階段，從研究和開發到市場開拓。然而，隨著藥品管道變得更加複雜和監管要求的增加，許多公司已轉向將這些專門的測試功能外包給外部合作夥伴。這種轉變使製藥公司能夠專注於其核心競爭力，例如藥物發現和商業化，同時利用委外研發機構(CRO) 的專業知識來提供分析測試服務。

如今，外包已成為藥品研發（R&D）不可或缺的一部分。藥物分析測試包括原料測試、測試方法開發、穩定性測試、生物分析服務和產品放行測試等廣泛的服務。透過外包這些服務，製藥公司現在無需大量資本投資即可獲得尖端技術、先進設備和監管專業知識。因此，外包市場呈指數級成長，CRO 提供全套服務，以滿足小型生物技術公司到大型製藥公司的需求。

技術進步如何形塑藥物分析測試外包市場？

技術進步透過提高測試過程的準確性、效率和速度，在塑造藥物分析測試外包市場方面發揮重要作用。推動該市場的最重要的技術創新之一是採用先進的分析儀器和高通量篩檢技術。這些儀器，例如液相層析法質譜 (LC-MS) 和核磁共振 (NMR) 光譜，可提供更高的精度和更快的分析時間，使 CRO 能夠快速、準確地處理大量樣品。這些技術對於識別和量化複雜分子和雜質尤其重要，這使得它們對於藥物測試至關重要。除了設備之外，自動化和機器人技術還徹底改變了實驗室工作流程，提高了效率並減少了人為錯誤的可能性。自動化系統可以管理高度重複的任務，例如樣品製備、資料收集和分析，確保結果的一致性和可重複性。這在高通量篩檢和穩定性測試等需要同時處理數千個樣品的領域尤其有價值。此外，雲端運算和資料分析的整合使製藥公司和 CRO 能夠更有效地儲存、共用和分析資料，簡化全球團隊之間的協作並確保遵守資料完整性法規。

推動藥物分析測試外包的主要市場趨勢是什麼？

幾個關鍵的市場趨勢正在推動藥物分析測試外包的成長。對生技藥品和生物相似藥的日益關注對先進分析測試服務的需求產生了重大影響。由於生技藥品比傳統的小分子藥物更大、更複雜，因此需要更嚴格和專門的測試通訊協定來確保品質、功效和安全性。憑藉生物分析測試方面的專業知識，CRO 已成為開發這些治療方法的製藥公司的重要合作夥伴，特別是在生技藥品的監管要求變得更加嚴格的情況下。影響市場的另一個主要趨勢是加強對藥物開發的監管。美國食品藥物管理局(FDA) 和歐洲藥品管理局(EMA) 等監管機構正在收緊藥品安全、品質和功效的指導方針，製藥公司正在利用其在監管合規性和高品質測試方面的專業知識。這包括測試雜質、穩定性和劣化，以及確保製造流程符合良好生產規範 (GMP)。專業和個人化藥物的激增也增加了對更專業的檢測服務的需求。個人化治療，尤其是基於遺傳或罕見疾病的治療，通常需要高度專業化的分析方法，而許多製藥公司可能沒有能力在內部執行這些方法。因此，製藥公司擴大將其測試需求外包給專門從事藥物開發利基領域的 CRO。此外，向虛擬製藥模式的轉變（製藥公司僅專注於藥物開發並將所有其他職能外包）進一步加速了對綜合分析測試服務的需求。

推動藥物分析測試外包市場成長的關鍵因素

有多個因素推動藥物分析測試外包市場的成長，每個因素都會增加對外部服務供應商的依賴。主要因素之一是藥物分子的複雜性不斷增加，特別是在生技藥品和生物相似藥領域。這些藥物需要更複雜的分析測試方法來確保其安全性、純度和功效，需要使用製藥公司內部通常缺乏的高度專業化的設備和專業知識。因此，公司擴大將這些業務外包給擁有處理複雜生技藥品測試的技術力和監管知識的 CRO。推動成長的另一個關鍵因素是外包為製藥公司帶來的成本節約潛力。透過外包分析測試，公司可以避免對昂貴的設備和基礎設施進行大量資本投資，並降低與人員配備和維護內部實驗室相關的成本。這對於沒有資源開發內部測試能力，但需要獲得高品質分析服務來開發候選藥物的小型生物技術公司和新興企業尤其有吸引力。由於製藥公司面臨世界各地監管機構日益嚴格的要求，監管壓力也推動了外包需求。具有監管合規專業知識的 CRO 透過確保測試流程符合全球標準並降低核准流程中延遲和拒絕的風險來提供明顯的優勢。此外，藥物開發全球化的趨勢意味著製藥公司跨多個地區業務，每個地區都有自己的監管要求。這導致人們越來越依賴具有全球企業發展和應對複雜監管環境的 CRO。最後，數位技術和資料分析的快速發展使外包成為尋求最佳化研發流程的製藥公司的一個有吸引力的選擇。憑藉先進的資料分析能力，CRO 可以深入了解試驗結果、加快決策速度並提高整體藥物開發效率。這些因素，加上對個人化和專業藥物不斷成長的需求，確保藥物分析測試外包市場將繼續強勁成長。

受訪企業範例（共42例）

Bioreliance
Boston Analytical
Charles River Laboratories International, Inc.
Dalton Pharma Services
Eurofins Scientific
Exova
Halo Pharma
Intertek Group PLC
Pace Analytical Services, LLC
Pharmaceutical Product Development, LLC
SGS SA
Toxikon, Inc.
West Pharmaceutical Services, Inc.
WuXi AppTec, Inc.

The global market for Pharmaceutical Analytical Testing Outsourcing estimated at US$10.3 Billion in the year 2023, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Bioanalytical Testing Service, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Method Development & Validation Service segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 6.2% CAGR

The Pharmaceutical Analytical Testing Outsourcing market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Pharmaceutical Analytical Testing Outsourcing Market – Key Trends & Drivers Summarized

How Has the Pharmaceutical Analytical Testing Outsourcing Industry Evolved Over Time?

The pharmaceutical analytical testing outsourcing industry has undergone a profound evolution over the past two decades, primarily driven by the increasing complexity of drug development, regulatory scrutiny, and the need for cost efficiencies. Traditionally, pharmaceutical companies conducted most of their analytical testing in-house, managing all stages of drug development from research to market entry. However, as drug pipelines have grown more complex and regulatory demands have increased, many companies have begun outsourcing these specialized testing functions to external partners. This shift allows pharmaceutical companies to focus on their core competencies, such as drug discovery and commercialization, while leveraging the expertise of contract research organizations (CROs) for analytical testing services.

Today, outsourcing has become a vital component of pharmaceutical research and development (R&D). Pharmaceutical analytical testing encompasses a wide range of services including raw material testing, method development, stability testing, bioanalytical services, and product release testing. Outsourcing these services has allowed pharmaceutical companies to access state-of-the-art technology, advanced instrumentation, and regulatory expertise without the need for significant capital investment. As a result, the outsourcing market has grown exponentially, with CROs offering a comprehensive suite of services to meet the demands of both small biotech firms and large pharmaceutical companies alike.

How Are Technological Advancements Shaping the Pharmaceutical Analytical Testing Outsourcing Market?

Technological advancements are playing a critical role in shaping the pharmaceutical analytical testing outsourcing market by improving the accuracy, efficiency, and speed of testing processes. One of the most significant innovations driving this market is the adoption of advanced analytical instruments and high-throughput screening technologies. These instruments, such as liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy, offer higher precision and faster analysis times, enabling CROs to handle large volumes of samples quickly and accurately. These technologies are particularly important for the identification and quantification of complex molecules and impurities, making them indispensable in pharmaceutical testing. In addition to instrumentation, automation and robotics have revolutionized laboratory workflows, allowing for greater efficiency and reducing the chances of human error. Automated systems can manage large volumes of repetitive tasks such as sample preparation, data collection, and analysis, ensuring consistent and reproducible results. This has become particularly valuable in areas like high-throughput screening and stability testing, where thousands of samples may need to be processed simultaneously. Additionally, the integration of cloud computing and data analytics has enabled pharmaceutical companies and CROs to store, share, and analyze data more efficiently, streamlining collaboration across global teams and ensuring compliance with data integrity regulations.

What Are the Key Market Trends Driving Outsourcing in Pharmaceutical Analytical Testing?

Several key market trends are driving the growth of outsourcing in pharmaceutical analytical testing. The increasing focus on biologics and biosimilars has significantly impacted the demand for advanced analytical testing services. Biologics, which are larger and more complex than traditional small-molecule drugs, require more rigorous and specialized testing protocols to ensure quality, efficacy, and safety. CROs with expertise in bioanalytical testing are becoming essential partners for pharmaceutical companies developing these therapies, especially as regulatory requirements for biologics become more stringent. Another major trend influencing the market is the rising regulatory scrutiny in drug development. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are enforcing stricter guidelines on drug safety, quality, and efficacy, prompting pharmaceutical companies to seek out CROs that can provide expertise in regulatory compliance and high-quality testing. This includes testing for impurities, stability, and degradation, as well as ensuring that manufacturing processes adhere to Good Manufacturing Practices (GMP). The increasing prevalence of specialty and personalized medicines is also driving the need for more specialized testing services. Personalized therapies, particularly those based on genetics or rare diseases, often require highly specific analytical methods, which many pharmaceutical companies may not have the in-house capability to perform. As a result, these companies are increasingly outsourcing their testing needs to CROs that specialize in niche areas of drug development. Additionally, the shift toward virtual pharma models, where companies focus exclusively on drug development and outsource all other functions, has further accelerated the demand for comprehensive analytical testing services.

Key Factors Fueling the Growth of the Pharmaceutical Analytical Testing Outsourcing Market

The growth in the pharmaceutical analytical testing outsourcing market is driven by several factors, each contributing to the increasing reliance on external service providers. One of the key drivers is the rising complexity of drug molecules, particularly in the biologics and biosimilars sector. These drugs require more sophisticated analytical testing methods to ensure their safety, purity, and efficacy, which often necessitates the use of highly specialized equipment and expertise that pharmaceutical companies may lack internally. This has prompted the outsourcing of these tasks to CROs that possess the technological capabilities and regulatory know-how to handle complex biologics testing. Another critical factor fueling growth is the cost-saving potential that outsourcing offers pharmaceutical companies. By outsourcing analytical testing, companies can avoid significant capital investment in expensive equipment and infrastructure while also reducing the costs associated with staffing and maintaining in-house laboratories. This is especially appealing to smaller biotech firms or start-ups that may lack the resources to develop in-house testing capabilities but require access to high-quality analytical services to advance their drug candidates. Regulatory pressures are also driving the demand for outsourcing, as pharmaceutical companies face increasingly stringent requirements from regulatory agencies worldwide. CROs with expertise in regulatory compliance offer a distinct advantage by ensuring that testing processes meet global standards, mitigating the risk of delays or rejections during the approval process. Additionally, the growing trend toward globalization in drug development means that pharmaceutical companies are working across multiple geographic regions, each with its own regulatory requirements. This further increases the reliance on CROs that have a global footprint and the ability to navigate complex regulatory landscapes. Lastly, the rapid advancements in digital technologies and data analytics have made outsourcing an attractive option for pharmaceutical companies looking to optimize their R&D processes. CROs that offer advanced data analytics capabilities can provide deeper insights into testing results, accelerating decision-making and improving the overall efficiency of drug development. These factors, combined with the growing demand for personalized and specialized medicines, ensure that the pharmaceutical analytical testing outsourcing market will continue to experience robust growth in the years to come.

Select Competitors (Total 42 Featured) -

Bioreliance
Boston Analytical
Charles River Laboratories International, Inc.
Dalton Pharma Services
Eurofins Scientific
Exova
Halo Pharma
Intertek Group PLC
Pace Analytical Services, LLC
Pharmaceutical Product Development, LLC
SGS SA
Toxikon, Inc.
West Pharmaceutical Services, Inc.
WuXi AppTec, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Pharmaceutical Analytical Testing Outsourcing - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Complexity of Drug Development and Regulatory Compliance Drives Demand for Outsourced Pharmaceutical Analytical Testing Services
- Increasing Stringent Regulatory Requirements from Global Health Authorities, Including FDA and EMA, Fuels Growth in Analytical Testing Outsourcing
- Growing Focus on Cost Efficiency and Speed-to-Market in Drug Development Spurs Demand for Outsourcing Analytical Testing Services
- Technological Advancements in Analytical Testing, Including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry, Enhance Testing Accuracy
- Expansion of Biologics and Biosimilars Development Strengthens Demand for Specialized Analytical Testing Outsourcing
- Increased Adoption of Outsourcing in Emerging Markets Drives Growth of Analytical Testing Services in Asia-Pacific and Latin America
- Rising Focus on Quality Control and Assurance in Drug Manufacturing Propels Demand for Outsourced Stability and Microbial Testing
- Growing Need for Advanced Testing Capabilities in Pharmaceutical Packaging, Including Extractables and Leachables Testing
- Emerging Use of Outsourced Analytical Testing for Preclinical and Clinical Trials Fuels Growth in Early-Stage Drug Development
- Rising Demand for Analytical Testing Outsourcing in the Development of Personalized Medicine and Gene Therapies
- Technological Innovations in Automation and AI-Powered Analytical Testing Solutions Enhance Efficiency and Data Accuracy
- Expansion of Contract Research Organizations (CROs) Offering End-to-End Analytical Testing Services Drives Market Growth
- Growing Use of Outsourced Analytical Testing in Generic Drug Development and Approval Processes
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
- TABLE 3: World Recent Past, Current & Future Analysis for Bioanalytical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 4: World 7-Year Perspective for Bioanalytical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Method Development & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World 7-Year Perspective for Method Development & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Stability Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World 7-Year Perspective for Stability Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 9: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 10: World 7-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 11: World Pharmaceutical Analytical Testing Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 12: USA Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 13: USA 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 15: Canada 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
JAPAN
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 16: Japan Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 17: Japan 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
CHINA
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 18: China Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 19: China 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
EUROPE
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 20: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
- TABLE 22: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 23: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
FRANCE
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 24: France Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 25: France 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
GERMANY
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 26: Germany Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 27: Germany 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
ITALY
- TABLE 28: Italy Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 29: Italy 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
UNITED KINGDOM
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 30: UK Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 31: UK 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
REST OF EUROPE
- TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: Rest of Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
ASIA-PACIFIC
- Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 35: Asia-Pacific 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
REST OF WORLD
- TABLE 36: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 37: Rest of World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030